Go to what we do

Succession planning

Securing what comes next

Handing over your company is both a business decision and a personal one. It’s not just about the price but also about the future of your life’s work, your employees and your family. Timing is one of the most important factors in a successful business succession, and the earlier you start, the more options you have to choose from.

We support entrepreneurs and family-owned businesses with every kind of succession journey, from a handover within the family or to your management team to an acquisition by an external buyer. Our advisors help you choose the right moment, weigh each alternative against your personal and financial goals, strengthen the value drivers buyers look for and manage a structured process through to signing. From the first conversation to the transition after closing, we partner with you to ensure continuity for your management, employees and customers.

Contact advisor
Cerbios-Pharma has been acquired by HAS Healthcare
Healthcare

Cerbios-Pharma has been acquired by HAS Healthcare

Cerbios-Pharma S.A. has been acquired by HAS Healthcare Advanced Synthesis S.A., forming a leading global contract development and manufacturing organization (CDMO) group. This transaction results in a seamless integration of complementary capabilities, combining extensive expertise in production, chemical and biological sciences and technical excellence, all designed to meet the evolving demands of the global pharmaceutical sector.

Learn more
Extramet has been acquired by ADMETOS
Industrial Machinery & Components

Extramet has been acquired by ADMETOS

EXTRAMET AG has been acquired by an investment company advised by ADMETOS GmbH. This transaction secures the succession of long-standing owner Hans-Jörg Mihm, who is retiring after more than four decades of entrepreneurial leadership. The new owner is committed to the company’s long-term development, with plans to strengthen its market position and unlock operational improvement potential.

Learn more
KKR to invest in Precipart Group Ltd.
Private Equity | Healthcare | Industrial Machinery & Components

KKR to invest in Precipart Group Ltd.

Kohlberg Kravis Roberts (KKR) has agreed to make a significant strategic investment in Precipart Group Ltd., a leading contract manufacturer of precision components for the medical device and aerospace industries. KKR plans to support the company in its continued growth organically and through M&A.

Learn more

Talk to our local advisors

Dr. Daniel Spring

Partner
Bern, Switzerland
Oaklins Switzerland

Dr. Jürg Stucker

Partner
Zurich, Switzerland
Oaklins Switzerland

David Zuerrer

Partner
Basel, Switzerland
Oaklins Switzerland